Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature

Int J Dermatol. 2024 Mar;63(3):399-401. doi: 10.1111/ijd.17016. Epub 2024 Jan 10.

Authors

Luca Valtellini^{1

2}, Francesca Barei¹, Martina Zussino¹, Angelo V Marzano^{1

2}, Silvia M Ferrucci¹

Affiliations

¹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

PMID: 38200658
DOI: 10.1111/ijd.17016

No abstract available

Publication types

Review
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Chronic Urticaria*
Humans
Urticaria* / drug therapy

Substances

dupilumab
Antibodies, Monoclonal, Humanized

Grants and funding